価格表

在庫・価格 : 2024年04月20日 04時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-ARID1A, Rabbit-Poly
データシート
HPA005456 AABアトラスアンチボディーズ
Atlas Antibodies AB
100 μl ¥96,000
(未発注)
追加

在庫・価格 : 2024年04月20日 04時43分 現在

Anti-ARID1A, Rabbit-Poly

  • 商品コード:HPA005456
  • メーカー:AAB
  • 包装:100μl
  • 価格: ¥96,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Yamamoto S et al. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations. Mod. Pathol. 2012 Apr;25(4):615-24
Yamamoto S et al
2012/01/01
PubMed
2 Yamamoto S et al. PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma. Virchows Arch. 2012 Jan;460(1):77-87
Yamamoto S et al
2012/01/01
PubMed
3 Wang K et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat. Genet. 2011 Dec;43(12):1219-23
Wang K et al
2011/01/01
PubMed
4 Guan B et al. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am. J. Surg. Pathol. 2011 May;35(5):625-32
Guan B et al
2011/01/01
PubMed
5 Bolander A et al. The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas. Cancer Genomics Proteomics ;5(6):293-300
Bolander A et al
PubMed
6 Wu CH et al. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int. J. Gynecol. Pathol. 2012 Jul;31(4):297-303
Wu CH et al
2012/01/01
PubMed
7 Ayhan A et al. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int. J. Gynecol. Cancer 2012 Oct;22(8):1310-5
Ayhan A et al
2012/01/01
PubMed
8 Wiegand KC et al. A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphoryla
Wiegand KC et al
2014/01/01
PubMed
9 Streppel MM et al. Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett"s esophagus. Oncogene 2014 Jan;33(3):347-57
Streppel MM et al
2014/01/01
PubMed
10 Guan B et al. Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions. Neoplasia 2012 Oct;14(10):986-93
Guan B et al
2012/01/01
PubMed
  • No.: 1
  • 文献情報:
    Yamamoto S et al. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations. Mod. Pathol. 2012 Apr;25(4):615-24
    Yamamoto S et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Yamamoto S et al. PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma. Virchows Arch. 2012 Jan;460(1):77-87
    Yamamoto S et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Wang K et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat. Genet. 2011 Dec;43(12):1219-23
    Wang K et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Guan B et al. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am. J. Surg. Pathol. 2011 May;35(5):625-32
    Guan B et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Bolander A et al. The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas. Cancer Genomics Proteomics ;5(6):293-300
    Bolander A et al
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Wu CH et al. Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int. J. Gynecol. Pathol. 2012 Jul;31(4):297-303
    Wu CH et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Ayhan A et al. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int. J. Gynecol. Cancer 2012 Oct;22(8):1310-5
    Ayhan A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Wiegand KC et al. A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphoryla
    Wiegand KC et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Streppel MM et al. Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett"s esophagus. Oncogene 2014 Jan;33(3):347-57
    Streppel MM et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Guan B et al. Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions. Neoplasia 2012 Oct;14(10):986-93
    Guan B et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed